Mangosteen

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: immunity inflammation skin

Research Overview

Overall, mangosteen (Garcinia mangostana) research has focused most heavily on its pericarp-derived xanthones—especially α-mangostin—and their bioactivities in preclinical models. Across multiple reviews, the dominant themes are anticancer/antitumor potential (anti-proliferative and pro-apoptotic effects), anti-inflammatory and antioxidant actions, and modulation of cell signaling pathways relevant to carcinogenesis (initiation, promotion, progression) and, to a lesser extent, neurological disease mechanisms. A parallel but smaller body of work addresses formulation and delivery challenges (e.g., nanoparticles, self-microemulsions) to improve α-mangostin’s poor water solubility, pharmacokinetics, and target selectivity. Additional applied research directions include recovery of polyphenols from mangosteen and other tropical fruit wastes for food-industry use, and the identification of Saccharomyces cerevisiae var. boulardii from mangosteen-associated sources in the context of probiotic/fermented food applications (not specific to mangosteen phytochemicals per se).

The strongest evidence supports that mangosteen xanthones have robust in vitro bioactivity—particularly antioxidant, anti-inflammatory, anti-proliferative, and apoptosis-inducing effects—and that these effects can translate into anticancer signals in animal models for some settings. Human data, as summarized in the studies, most consistently support tolerability/safety of mangosteen products and measurable antioxidant activity in clinical contexts, but do not yet establish clinical anticancer efficacy. Reviews also emphasize that aggressive commercial “superfruit” claims have outpaced the depth of in vivo and especially human evidence, and that bioavailability and metabolism are key determinants of whether promising cellular mechanisms are achievable in humans at practical doses.

Major research gaps include: (1) well-controlled human clinical trials evaluating clinically meaningful endpoints (particularly for cancer prevention/therapy, inflammation-related conditions, and neurological indications); (2) clearer characterization of absorption, metabolism, tissue distribution, and exposure–response relationships for individual xanthones and standardized extracts; (3) mechanistic clarification and comparative evaluation of “lesser” xanthones (e.g., gartanin, β-/γ-mangostin, garcinones) and non-pericarp plant parts, where activity is suggested but mechanisms are less developed; and (4) optimization and validation of delivery systems (nanoparticles, microemulsions) with demonstrated improvements in human pharmacokinetics and efficacy. Standardization of mangosteen preparations, dose selection, and safety assessment for long-term or high-dose use are also recurring needs to bridge preclinical promise to clinical utility.

1. What conditions has Mangosteen been studied for?

  • Cancer / tumors (chemoprevention and therapy-related mechanisms): Multiple studies focus on mangosteen xanthones—especially α-mangostin—for anti-proliferative and pro-apoptotic effects in cancer models (cell studies and animal models), and broader “anticancer/antitumor” potential across various cancers.

  • Neurological diseases (preclinical): One review specifically highlights α-mangostin’s potential in “managing cancer and neurological diseases,” emphasizing mechanisms and preclinical applications.

  • Inflammation-related conditions: Mangosteen xanthones are repeatedly described as anti-inflammatory; one abstract also mentions disclosed application in rheumatoid arthritis (with formulation work to improve pharmacokinetics).

  • Cardiovascular and gastrointestinal health (emerging/summary claims): A review notes more recent findings that α-mangostin may help “maintain cardiovascular system and gastrointestinal health.”

  • Metabolic disease (preclinical/medicinal use summaries): A 2016–2018 review summary includes mangosteen use in anti-diabetes contexts.

  • Infectious diseases / antimicrobial activity (preclinical): Xanthones are described as antibacterial/antifungal/antiviral in review summaries. Separately, a yeast isolated from mangosteen environments (Saccharomyces boulardii) is discussed for GI infectious disease prophylaxis, but that evidence pertains to the yeast as a probiotic rather than mangosteen xanthones themselves.

  • Skin/cosmetic applications: α-mangostin is described as having cosmetic uses (anti-aging, anti-wrinkle, acne, skin lubrication) in a review.

  • Organ-protective claims (review-level): A review summary states mangosteen extracts may protect liver, skin, joint, eye, neuron, bowel, and cardiovascular tissues “against disorders and diseases.”

2. Does it work in treating those conditions? Summarize the evidence.

  • Cancer: The studies consistently support preclinical anticancer activity (in vitro and animal models). Reviews report that xanthones (especially α-mangostin) can inhibit proliferation, induce apoptosis, and modulate signaling pathways and cancer-related proteins. One abstract notes α-mangostin has shown potency in “numerous different cancer cell studies and cancer animal models.” Another emphasizes effects across stages of carcinogenesis (initiation, promotion, progression) and on processes like apoptosis, inflammation, and metastasis. However, a key limitation is that clinical anticancer activity in humans has not yet been evaluated in the cited review, despite mangosteen products appearing safe and tolerated in human trials.

  • Liver cancer cell model (HepG2): One experimental abstract reports mangosteen peel extracts rich in xanthones (with α-mangostin as the dominant compound) and describes that a xanthone nanoemulsion was more effective than xanthone extract in inhibiting HepG2 cell growth (cell-culture evidence; not clinical).

  • Neurological diseases: Evidence in the studies is framed as therapeutic potential and preclinical applications with mechanistic focus; no human efficacy outcomes are provided.

  • Inflammatory conditions / rheumatoid arthritis: The studies support anti-inflammatory activity broadly (mostly mechanistic/preclinical). Rheumatoid arthritis is mentioned as an application that “has been disclosed,” but the study does not provide clinical trial outcomes; it also highlights formulation work (self-microemulsion) to address pharmacokinetic limitations.

  • Cardiovascular, gastrointestinal health, diabetes, antimicrobial uses: These are presented mainly as review-level summaries of reported activities/uses. The studies do not provide specific human trial endpoints demonstrating treatment efficacy for these conditions.

  • Human evidence (overall): The anticancer-focused review states mangosteen products in human clinical trials show antioxidant activity and are well tolerated, but clinical anticancer efficacy has not been evaluated in those trials (per the study).

3. What health benefits does it have?

  • Antioxidant activity: Multiple studies describe mangosteen xanthones (notably α-mangostin) as antioxidants. Human trials mentioned in one review showed antioxidant activity (without detailing specific clinical outcomes in the study).

  • Anti-inflammatory effects: Xanthones are repeatedly described as anti-inflammatory, and one review updates in vitro/in vivo anti-inflammatory data and highlights the need for more research on absorption/metabolism/efficacy.

  • Anticancer-related biological effects (preclinical): Benefits described include anti-proliferative, pro-apoptotic, and anti-carcinogenic activities, with modulation of signaling pathways and molecular targets relevant to cancer biology.

  • Antimicrobial properties (preclinical): Reviews attribute antibacterial, antifungal, and antiviral activities to mangosteen xanthones.

  • Potential organ/tissue protective effects (review summaries): A review summary describes protective benefits for multiple organs (e.g., liver, neuron, bowel, cardiovascular tissues), but the studies do not provide specific clinical endpoints.

  • Formulation-driven potential improvements: Because α-mangostin has poor water solubility and limited target selectivity, several studies highlight nanoparticle/nanoemulsion/self-microemulsion delivery systems as a way to improve pharmacological performance (e.g., stronger in vitro inhibition with nanoemulsion vs extract in HepG2 cells).

4. Does it have any downsides or side effects?

  • Pharmacokinetic/formulation limitations: A major downside noted is that α-mangostin has low water solubility and poor target selectivity, contributing to limited clinical application. Other studies emphasize the need to better understand bioavailability, absorption, metabolism, and efficacy.

  • Evidence gaps in humans: Despite extensive in vitro and animal data and strong marketing as a “superfruit,” one review highlights that there have been very limited animal and human studies relative to commercial claims, and calls for more research on absorption/metabolism/efficacy.

  • Tolerability/safety in humans (limited detail): One anticancer-focused review states mangosteen products appear safe and have been well tolerated in human clinical trials, but the studies reviewed here do not list specific adverse events, dose ranges, or long-term safety outcomes.

  • Other side effects: The studies reviewed here do not describe specific side effects, contraindications, or drug–supplement interactions.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report pharmacogenomic findings (e.g., effects modified by genetic variants in drug-metabolizing enzymes, transporters, or molecular targets). Several reviews emphasize the importance of understanding bioavailability and metabolism of mangosteen xanthones, which are areas where genetic variation could plausibly matter, but no genotype-specific benefits or harms are described in the studies.

References

  1. Biochemical features and therapeutic potential of α-Mangostin: Mechanism of action, medicinal values, and health benefits.
    Manzar Alam, Summya Rashid, Kisa Fatima, Mohd Adnan, Alaa Shafie, Mohammad Salman Akhtar, A H Ganie, Sayed M Eldin, Asimul Islam, Ilyas Khan, Md Imtaiyaz Hassan (2023) - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  2. The purple mangosteen (Garcinia mangostana): Defining the anticancer potential of selected xanthones.
    Mirielle C Nauman, Jeremy J Johnson (2022) - Pharmacological research
  3. Current trends of tropical fruit waste utilization.
    Choon Yoong Cheok, Noranizan Mohd Adzahan, Russly Abdul Rahman, Nur Hanani Zainal Abedin, Norhayati Hussain, Rabiha Sulaiman, Gun Hean Chong (2018) - Critical reviews in food science and nutrition
  4. Insights into the Chemical Composition and In Vitro Bioactive Properties of Mangosteen (
    Bianca R Albuquerque, Maria Inês Dias, José Pinela, Ricardo C Calhelha, Tânia C S P Pires, Maria José Alves, Rúbia C G Corrêa, Isabel C F R Ferreira, Maria Beatriz P P Oliveira, Lillian Barros (2023) - Foods (Basel, Switzerland)
  5. Biological activities and bioavailability of mangosteen xanthones: a critical review of the current evidence.
    Fabiola Gutierrez-Orozco, Mark L Failla (2013) - Nutrients
  6. Xanthones from mangosteen extracts as natural chemopreventive agents: potential anticancer drugs.
    T Shan, Q Ma, K Guo, J Liu, W Li, F Wang, E Wu (2011) - Current molecular medicine
  7. Bioactivity and pharmacological properties of α-mangostin from the mangosteen fruit: a review.
    Guoqing Chen, Yong Li, Wei Wang, Liping Deng (2018) - Expert opinion on therapeutic patents
  8. Antidotal and protective effects of mangosteen (
    Aidin Mohammadi Zonouz, Mahboobeh Ghasemzadeh Rahbardar, Hossein Hosseinzadeh (2023) - Iranian journal of basic medical sciences
  9. Mangosteen for malignancy prevention and intervention: Current evidence, molecular mechanisms, and future perspectives.
    Lindsay S Kalick, Hamaad A Khan, Erica Maung, Yasmany Baez, Alexa N Atkinson, Carly E Wallace, Faith Day, Blake E Delgadillo, Arijit Mondal, Ramida Watanapokasin, Sandra M Barbalho, Anupam Bishayee (2023) - Pharmacological research
  10. A Review of the Influence of Various Extraction Techniques and the Biological Effects of the Xanthones from Mangosteen (
    Vasin Yuvanatemiya, Pao Srean, Wiyada Kwanhian Klangbud, Karthikeyan Venkatachalam, Jittimon Wongsa, Thanya Parametthanuwat, Narin Charoenphun (2022) - Molecules (Basel, Switzerland)
  11. Quantification of Xanthone and Anthocyanin in Mangosteen Peel by UPLC-MS/MS and Preparation of Nanoemulsions for Studying Their Inhibition Effects on Liver Cancer Cells.
    Rui Li, Baskaran Stephen Inbaraj, Bing-Huei Chen (2023) - International journal of molecular sciences
  12. Recent updates on metabolite composition and medicinal benefits of mangosteen plant.
    Wan Mohd Aizat, Ili Nadhirah Jamil, Faridda Hannim Ahmad-Hashim, Normah Mohd Noor (2019) - PeerJ
  13. Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles.
    Ha Thi Thu Do, Jungsook Cho (2020) - International journal of molecular sciences
  14. Modulation of the hypothalamic-pituitary-adrenal (HPA) axis by plants and phytonutrients: a systematic review of human trials.
    Adrian L Lopresti, Stephen J Smith, Peter D Drummond (2022) - Nutritional neuroscience
  15. Effects of dietary mangosteen peel powder and extract on the growth performance, meat quality and indicators for immunity, gut health and antioxidant activity in broiler chicks.
    Da-Hye Kim, Hyeon Mo Yang, Ju-Yong Song, Jina Park, Byung-Yeon Kwon, Anh Viet Vu, Dae Sung Lee, Kyung-Woo Lee (2024) - Poultry science
  16. Mangosteen Pericarp Processing Technology to Create Economic Value and Reduce Biowaste.
    Alisa Soontornwat, Thadchapong Pongsuttiyakorn, Samak Rakmae, Eakasit Sritham, Panmanas Sirisomboon, Umed Kumar Pun, Warawut Krusong, Pimpen Pornchaloempong (2024) - Foods (Basel, Switzerland)
  17. Antitumor and anti-nematode activities of α-mangostin.
    Joanna Markowicz, Łukasz Uram, Justyna Sobich, Laura Mangiardi, Piotr Maj, Wojciech Rode (2019) - European journal of pharmacology
  18. Botanical characteristics, chemical components, biological activity, and potential applications of mangosteen
    Chenchen Bi, Hang Xu, Jingru Yu, Zhinan Ding, Zheng Liu (2023)


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!